. Time-dependent reversal of sepsis-induced PMN uptake and lung vascular injury by expression of CD18 antagonist. Am J Physiol Lung Cell Mol Physiol 282: L796-L802, 2002. First published November 16, 2001 10.1152/ajplung.00298.2001.-We determined the time-dependent effects of conditional expression of neutrophil inhibitory factor (NIF), a specific 41-kDa CD18 integrin antagonist, on the time course of NIF expression and lung PMN (polymorphonuclear leukocyte) infiltration and vascular injury in a model of Escherichia coli-induced sepsis in mice. Studies were made in mice transduced with the Eselectin (ES) promoter-NIF construct (using liposomes) in which the NIF cDNA was driven by the inflammation-and endothelial cell-specific ES promoter. We observed time-dependent expression of NIF in pulmonary vascular endothelium that paralleled the ES expression. Expression of both was evident at 1 h after E. coli challenge, peaked at 3-6 h, and returned to basal level within 48 h. We observed that increases in PMN uptake and transalveolar PMN migration induced by E. coli challenge were reversed in a time-dependent manner following NIF expression in mice. NIF expression also prevented the progression of lung vascular injury and edema formation following E. coli challenge. Thus the conditional expression of NIF using the ES promoter can reverse, in a time-dependent manner, lung PMN infiltration and vascular injury induced by gram-negative sepsis. The results support the model that initial engagement of CD18 integrins enables the further recruitment of additional PMN into lung tissues such that PMN continue to sequester and migrate after E. coli challenge. E-selectin promoter; gram-negative sepsis; CD18 blockade; polymorphonuclear leukocyte migration and uptake; lung vascular permeability LEUKOCYTE TRAFFICKING IN PULMONARY tissue and air spaces is critical in the host defense response; however, migration and activation of polymorphonuclear leukocytes (PMN) into lungs also contribute to the mechanism of inflammatory tissue injury (10, 24, 25) . It is well accepted that PMN migration from the blood vessels to site of infection occurs by a multistep process dictated by sequential activation of adhesive proteins and their counterreceptors on PMN and endothelial cells (3, 22, 12) . Initiation of PMN migration begins with "capture" of PMN by endothelial cells, and this is followed by PMN "rolling" along the vessel wall mediated by adhesive proteins of the selectin family (1, 2, 23). Rolling PMN become firmly adherent to endothelial cells following activation of intercellular adhesion molecule-1 (ICAM-1) (4, 9, 11). The cells are thus positioned for migration into tissue parenchyma and then into the alveolar space. E-selectin (ES) as well as L-selectin and P-selectin contribute to the capture and rolling of PMN, whereas ␤ 2 -integrins and ICAM-1 mediate firm adhesion of PMN to endothelial cells (16, 21, 26) .
E-selectin promoter; gram-negative sepsis; CD18 blockade; polymorphonuclear leukocyte migration and uptake; lung vascular permeability LEUKOCYTE TRAFFICKING IN PULMONARY tissue and air spaces is critical in the host defense response; however, migration and activation of polymorphonuclear leukocytes (PMN) into lungs also contribute to the mechanism of inflammatory tissue injury (10, 24, 25) . It is well accepted that PMN migration from the blood vessels to site of infection occurs by a multistep process dictated by sequential activation of adhesive proteins and their counterreceptors on PMN and endothelial cells (3, 22, 12) . Initiation of PMN migration begins with "capture" of PMN by endothelial cells, and this is followed by PMN "rolling" along the vessel wall mediated by adhesive proteins of the selectin family (1, 2, 23) . Rolling PMN become firmly adherent to endothelial cells following activation of intercellular adhesion molecule-1 (ICAM-1) (4, 9, 11). The cells are thus positioned for migration into tissue parenchyma and then into the alveolar space. E-selectin (ES) as well as L-selectin and P-selectin contribute to the capture and rolling of PMN, whereas ␤ 2 -integrins and ICAM-1 mediate firm adhesion of PMN to endothelial cells (16, 21, 26) .
Neutrophil inhibitory factor (NIF), a 41-kDa glycoprotein isolated from the canine hookworm (Ancylostoma caninum), was identified as a potent inhibitor of PMN adhesion to endothelial cells and adhesion-dependent release of hydrogen peroxide (17) . These effects of NIF result from its specific binding to the I-domain of CD11/CD18 ␤ 2 -integrins (15, 17, 18, 28) . NIF binds to CD11b with high affinity and CD11a with lower affinity (15) and prevents PMN adhesion to endothelial cells to a degree equivalent to anti-CD18 monoclonal antibodies (15) . We have shown that conditional expression of NIF using the E-selectin promoter (pES) is a useful strategy in preventing PMN adhesion to activated endothelial cells and resultant lung microvascular injury (27) . However, previous studies have not examined the time course of the response, i.e., the temporal relationship between expression of ES and NIF and the relationship between NIF expression and reversal of PMN infiltration and lung microvessel injury. In the present study, we used ES promoter to induce NIF expression since ES transcription is activated specifically in endothelial cells in response to inflammatory stimuli such as gram-negative septicemia (19) .
ments. These mice have been extensively used in models of endotoxemia. Moreover, we established the liposome-based method of gene delivery in these mice. Therefore, we have used these mice in the present study to express NIF as well as to examine Escherichia coli responses. Mice were housed in pathogen-free conditions at the University of Illinois Animal Care Facility where they were treated in accordance with institutional and National Institutes of Health guidelines. Before injection of transgene/liposome complex, mice were anesthetized with intramuscular injection of ketamine (60 mg/kg) and xylazine (2 mg/kg) in PBS.
DNA/liposome preparation and in vivo gene transfer. Dimethyldioctadecylammonium bromide (DDAB; Sigma Chemical, St. Louis, MO) and cholesterol (Calbiochem, La Jolla, CA) in chloroform were used to prepare the liposomes as described (6, 14, 29) . Briefly, the mixture consisting of DDAB and cholesterol (1:1 molar ratio) was dried using a Rotavapor R-124 (Brinkmann, Westbury, NY) and dissolved in 5% glucose. The lipid molecules were sonicated for 20 min. The construct pES-NIF in which NIF cDNA (a kind gift of Corvas, La Jolla, CA) is driven by the ES promoter was made as described (27) . The pES-NIF construct (50 g/mouse) and liposomes were combined at a ratio of 1 g of DNA to 8 nmol of liposomes and injected intravenously into mice.
Challenge of mice with E. coli. Mice received 1 ϫ 10 8 live E. coli (American Type Culture Collection 25992) in PBS (pH 7.4) via intraperitoneal injection. The E. coli dosage was chosen because it did not result in death of mice within the 48-h experimental period. Control mice were injected intraperitoneally with an equal volume of PBS. Mortality studies were carried out in another group of mice challenged with 1 ϫ 10 9 live E. coli injected intraperitoneally. Western blot analysis. Mouse lungs were homogenized in PBS (pH 7.4) containing protease inhibitor cocktail (66 l/10 ml PBS, Sigma) using a tissue grinder at a ratio of 1 g of lung to 5 ml of PBS. The homogenates were centrifuged at 1,000 rpm for 10 min at 4°C. Supernatants were collected, and the protein concentration of each sample was measured with Non-Interfering Protein Assay (Geno Technology, St. Louis, MO). An equal amount of protein from each sample (ϳ50 g) was resolved in 8% SDS-PAGE gel, and Western blot analysis was performed to determine the expression of ES and NIF as described (20) . A polyclonal antibody against ES was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). A polyclonal antibody against NIF was made using a peptide containing the COOH-terminal sequence of NIF (IPD-DGVCFIGSKADYDSKEFYRFREL). Densitometry of bands was performed using Scion Image software (Scion, Frederick, MD).
Immunocytochemistry. Lung sections (4 m) of mice were prepared as previously described (29) and stained with rabbit anti-NIF antiserum using the ImmunoCruz Staining System (Santa Cruz Biotechnology).
Lung PMN sequestration. Mouse lungs were homogenized in 5% hexadecyltrimethylammonium bromide (HTAB) in 50 mM phosphate buffer (pH 6; 5.0 ml of HTAB/g tissue) for quantification of PMN uptake by myeloperoxidase (MPO) activity (13) . The homogenates were centrifuged at 40,000 rpm for 30 min. The pellets were subjected to three cycles of freeze-thaw; each cycle was followed by homogenization and centrifugation. The three supernatants were collected and mixed; 0.1 ml of the pooled sample was mixed 1:30 (vol/vol) with assay buffer (0.167 mg/ml of O-dianisidine hydrochloride and 0.0005% H2O2), and the absorbance change was measured at 460 nm for 3 min. MPO activity was calculated as the change in absorbance over time.
PMN counts in bronchoalveolar lavage fluid. Bronchoalveolar lavage (BAL) was performed by cannulating the trachea with a blunt-ended 21-gauge needle, instilling 0.6 ml of sterile PBS containing 1 mM EDTA, and collecting the fluid by gentle aspiration. The total fluid (0.5 ml) was centrifuged for 5 min at 300 rpm using a cytospin3 (Shandon, Pittsburgh, PA), and BAL cells were stained with HEMA3 (Biochemical Sciences, Swedesboro, NJ). The total number of cells in BAL (which consisted mostly of macrophages and PMN) per slide were counted. Each slide was divided into 20 fields, and the total number of cells was calculated by multiplying the average number of cells in one field by 20. The number of PMN as a percentage of the total cells was calculated.
Pulmonary microvascular permeability and isogravimetric lung water determinations. Capillary filtration coefficient (K fc) was measured to determine pulmonary microvascular permeability to liquid as described (7). Briefly, after the standard 20-min equilibration perfusion, the outflow pressure was rapidly elevated by 10 cmH 2O for 2 min. The lung wet weight changed in a ramplike fashion, reflecting net fluid extravasation. At the end of each experiment, lungs were dissected free of nonpulmonary tissue, and lung dry weight was determined. K fc (ml ⅐ min Ϫ1 ⅐ cmH2O ⅐ g dry wt Ϫ1 ) was calculated from the slope of the recorded weight change normalized to the pressure change and to lung dry weight.
As another approach to assess the leakiness of pulmonary microvessels, we determined the rate of pulmonary edema formation by continuously monitoring the lung wet weight changes. Weight change of lungs obtained from different groups was followed for 90 min after the beginning of the perfusion. Because the perfusate albumin concentration was constant at the onset of perfusion and because pulmonary arterial pressure did not change during the 90-min monitoring period, the rate and magnitude of the increase in lung wet weight (i.e., attainment of a new isogravimetric state) provided an index of permeability of pulmonary microvessels.
Survival studies in mice challenged with E. coli. At 48 h after intravenous injection of pES-NIF/liposome complex, mice were challenged with a dosage of 10 9 E. coli per mouse intraperitoneally for mortality analysis. Mice not receiving injection of NIF construct were used as controls. A 50% survival rate after E. coli challenge was determined in all groups.
Statistical analysis. Data are expressed as means Ϯ SE. Comparisons between experimental groups were made by ANOVA with a significance value set at P Ͻ 0.05.
RESULTS

Time course of ES and NIF expression in mouse lungs induced with E. coli challenge.
In the group of mice challenged with intraperitoneal E. coli (10 8 live E. coli), Western blot analysis showed that ES expression was induced in a time-dependent manner after challenge with E. coli. ES expression was seen as early as 1 h, peaked at 6 h, and decreased at 48 h (Fig. 1A) . The time course of ES promoter-driven NIF expression was similar to ES (Fig. 1, A and B) . Western blot and immunohistochemical analyses of lungs from the pES-NIF-transduced mice showed that NIF expression peaked between 3 and 6 h and returned to basal levels by 24 h after E. coli challenge (Fig. 1, A and B) .
Time-dependent effects of conditional NIF expression on PMN uptake and migration in mouse lung. Lung MPO activity in control mice increased within 1 h after E. coli challenge, peaked at 6 h, and returned to base-line at 24 h (Fig. 2) . MPO activity of lungs conditionally expressing NIF after the E. coli challenge was reduced in a time-dependent manner by 65-90% of the control values (Fig. 2) . This temporal reduction in MPO activity paralleled the time course of NIF expression (Fig.  1) . Analysis of BAL fluid showed that the percentage of PMN in BAL fluid increased after challenge of E. coli; the response peaked at 12 h (11.2% of total recoverable cells were PMN) and returned toward baseline by 48 h (Fig. 3A) . In the group of mice in which lungs were transduced with pES-NIF, the increase in PMN in BAL fluid was significantly reduced in a time-dependent manner (by 75-100% of control values; Fig. 3A) , paralleling the NIF expression (Fig. 1) . The total number of cells in BAL fluid (which consisted primarily of macrophages and PMN) showed the same time-dependent changes (Fig. 3B) .
Time-dependent NIF expression prevents increased lung vascular permeability and edema formation induced with intraperitoneal E. coli. We quantified microvessel liquid permeability (as K fc ) and changes in isogravimetric lung water content to address the timedependent effects of conditional NIF expression on PMN-mediated lung microvessel injury. E. coli challenge resulted in time-dependent increases in extravascular lung water content (Fig. 4A ) and lung microvessel permeability (Fig. 4B) . The increases in lung water content and vascular permeability peaked 6 h after E. coli. Time-dependent expression of NIF reversed the progressive permeability increase and edema induced by E. coli in control mice (Fig. 4) .
Conditional NIF expression reduces mortality induced with lethal dosage of E. coli. We determined whether expression of NIF reduced mortality of mice challenged with E. coli. Because the sublethal dosage of E. coli did not produce death within 48 h of E. coli challenge, we used the 10-fold higher lethal dosage of E. coli in these mortality experiments. At 48 h after expression of pES-NIF, mice were challenged with 10 9 E. coli per mouse via intraperitoneal injection. Mice not receiving injection of NIF construct were used as controls. In the group of mice challenged with E. coli, 50% survived in the control group at 6 h, whereas 50% of the pES-NIF-expressing mice were alive at 8 h (Fig.  5 ). All control mice were dead at 9 h after E. coli challenge, whereas 40% of pES-NIF-expressing mice were alive at this time (Fig. 5) . Together, the data demonstrate that inducible expression of NIF not only prevents progression of lung vascular injury and edema formation but also reduces the mortality rate after E. coli challenge.
DISCUSSION
We reasoned that it would be possible to, in a timedependent manner, arrest the progression of PMN uptake and increased lung microvessel permeability using the endothelial cell-selective ES promoter to express the specific CD18 antagonist NIF. Because ES is expressed in endothelial cells by inflammatory stimuli such as gram-negative sepsis (5), this would be a potential means of conditionally and temporally preventing lung microvessel injury in an inflammation-specific manner. The results indicate that NIF expression had a similar time course as expression of ES and that the expression of NIF was silenced as ES expression decreased to basal levels. In the present study, we show the reversibility of lung tissue PMN uptake and transalveolar PMN migration and lung microvessel injury after E. coli-induced gram-negative septicemia. In previous studies, we showed that NIF can bind to CD11b with high affinity and to CD11a with low affinity (15) and that it thereby prevents PMN adhesion to endothelial cells to a degree equivalent to anti-CD18 monoclonal antibodies (15) . These effects of NIF result from its specific binding to the I-domain of CD11/CD18 ␤ 2 -integrins (15, 17, 18, 28) .
To study the time-dependent effects of the conditional NIF expression, we used the intraperitoneal E. coli challenge mouse model (10 8 live E. coli). E. coli challenge resulted in marked lung tissue PMN sequestration but with relatively few PMN migrating into the air space (at peak response, ϳ11% of cells in BAL fluid were PMN). These responses were time dependent in that PMN accumulated in lung interstitial tissue as early as 1 h after E. coli challenge, reached a peak value at 6 h, and returned to basal levels between 12 and 24 h. PMN migration into lung air space was, however, delayed and remained elevated for up to 12 h. The decrease in lung PMN uptake at 12 h suggests the existence of "antiadhesive" mechanisms, which are activated in vivo and capable of decreasing lung PMN uptake in the face of continued E. coli exposure. Thus the mechanisms responsible for PMN migration into the air space remained active even up to 12 h after E. coli challenge, whereas lung tissue PMN uptake at this time had been significantly inhibited. Fig. 2 . Time-dependent expression of NIF prevents the time-dependent increases in polymorphonuclear leukocyte (PMN) uptake in mouse lung. Mice were challenged with 1 ϫ 10 8 E. coli (intraperitoneal) at 48 h after the intravenous injection of pES-NIF/liposome complex. Mice without injection of complex were used as controls. Myeloperoxidase (MPO) activity increased within 1 h and peaked at 6 h after E. coli challenge. Time-dependent expression of NIF prevented the progressive PMN uptake by 65-90%. Bars indicate means Ϯ SE; n ϭ 5. *P Ͻ 0.05 compared with E. coli-challenged mice in the absence of NIF expression. **P Ͻ 0.05 compared with E. coli-challenged mice in the absence of NIF expression. We have shown in other studies that intratracheal E. coli challenge results in a peak response at which ϳ90% of cells in the air space are PMN (unpublished observations). Thus the route of E. coli challenge is an important determinant of transalveolar PMN migration. Nevertheless, the magnitude of PMN sequestration and migration after intraperitoneal E. coli challenge was sufficient to induce an approximate twofold increase in the K fc as early as 1 h post E. coli challenge. This finding suggests that the initial PMN uptake after the onset of septicemia is capable of inducing severe lung microvessel injury. Capillary filtration increased further at 6 h post-E. coli, indicating the progression of lung microvessel injury as PMN continued to accumulate in lungs in a time-dependent manner. Our finding that the pulmonary capillary coefficient returned to the basal value at 24 h after 10 8 E. coli challenge indicates that the endothelial barrier in this sublethal model is capable of reestablishing its barrier property.
NIF expression induced by E. coli prevented, in a time-dependent manner, PMN uptake by 65-90% and transalveolar PMN migration by 75-100% after the E. coli challenge. This finding demonstrates that CD18 blockade, as induced by the conditional release of NIF, can arrest the PMN uptake and transalveolar PMN migration responses. The results can be explained by the finding that NIF is released in the pulmonary microcirculation and binds to CD18 integrins on leukocytes (29) and thus prevents the progressive infiltration of PMN in lung tissue. The finding that NIF prevents the progression of PMN uptake and migration within the first 3 h of its expression suggests that CD18-dependent mechanisms are critical in mediating initial PMN uptake and migration responses in lungs.
The results support the model that initial engagement Values were obtained at different times from control mice challenged with 1 ϫ 10 8 E. coli (intraperitoneal) or mice that were injected intravenously with pES-NIF/liposome complex 48 h before E. coli challenge. Lung wet weight was continuously monitored (see METHODS) at the postchallenge times indicated on abscissa. The increase in isogravimetric lung water content peaked at 6 h after intraperitoneal E. coli challenge, and the response was reversed with expression of NIF. *P Ͻ 0.05 compared with control (basal value). B: time course of microvessel liquid permeability (measured as capillary filtration coefficient, Kfc) in lungs of control and pES-NIF-transduced mice following E. coli challenge. Kfc values were determined (see METHODS) at the times indicated on abscissa. Peak value of Kfc was observed at 6 h and was reversed by 70% with the expression of NIF. Bars indicate means Ϯ SE (n ϭ 5). *P Ͻ 0.05 compared with control group without the challenge of E. coli. **P Ͻ 0.05 compared with control E. coli-challenged group in the absence of NIF expression. Mice not receiving injection of NIF construct were used as controls. In mice challenged with intraperitoneal E. coli, a 50% survival rate was observed in control group at 6 h, whereas a 50% survival rate was observed at 8 h for mice expressing pES-NIF. At 9 h after the challenge of E. coli, none of the mice were alive in the control group, whereas 40% of mice expressing pES-NIF were alive at this time. Curves were generated from 2 independent experiments with a total of 15-20 mice per group. of CD18 integrins enables the further recruitment of additional PMN into lung tissues such that PMN continue to sequester and migrate during the 6-to 12-h period following E. coli challenge.
Lung wet weight and K fc were monitored to determine the time course of edema formation and increased pulmonary microvascular permeability, respectively. Previous studies have shown that these responses are dependent on CD18 integrins since CD18 antibodies prevented lung microvessel injury in this model (8) . In the present study, we show in mice challenged with intraperitoneal E. coli that lung wet weight and K fc increased progressively and peaked at 6 h, reflecting the time-dependent nature of lung microvessel injury. This finding indicates lung microvessel injury parallels the infiltration of PMN in lungs. Expression of NIF using the pES-NIF construct prevented the progressive increase in lung vascular permeability and edema formation, indicating that these responses were CD18 integrin dependent. Thus CD18 blockade, induced in a conditional manner, may enable the repair of lung microvascular injury by preventing the progressive infiltration of PMN.
Although our previous studies have shown a protective effect of NIF expression in mice (27, 29) , the present studies extend these observations by demonstrating the time-dependent nature of the response in which conditional NIF expression was coupled to reversal of lung tissue PMN uptake and transalveolar migration as well as lung microvessel injury. The conditional expression of NIF also significantly reduced mortality in mice challenged with a 10-fold higher dosage of E. coli than the sublethal dosage used for the functional studies.
In summary, findings based on the conditional timedependent expression of the selective CD18 integrin antagonist NIF suggest that engagement of PMN CD18 is required for the increases in PMN sequestration, transalveolar PMN migration, and increased lung microvessel permeability induced by gram-negative septicemia. Gene transfer based on gram-negative septicemia-induced expression of NIF may be useful in reversing lung PMN infiltration and lung vascular injury and edema formation. The advantage of this approach is that it is not only conditional (i.e., requiring the inflammatory stimulus for NIF induction) but also endothelial cell specific (it relies on ES promoter) and transient (it parallels ES expression).
